Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Total Liabilities: 2015-2024

Historic Total Liabilities for Wave Life Sciences (WVE) over the last 10 years, with Dec 2024 value amounting to $134.8 million.

  • Wave Life Sciences' Total Liabilities fell 47.87% to $109.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $109.0 million, marking a year-over-year decrease of 47.87%. This contributed to the annual value of $134.8 million for FY2024, which is 40.73% down from last year.
  • As of FY2024, Wave Life Sciences' Total Liabilities stood at $134.8 million, which was down 40.73% from $227.4 million recorded in FY2023.
  • In the past 5 years, Wave Life Sciences' Total Liabilities registered a high of $227.4 million during FY2023, and its lowest value of $134.8 million during FY2024.
  • Over the past 3 years, Wave Life Sciences' median Total Liabilities value was $183.6 million (recorded in 2022), while the average stood at $182.0 million.
  • In the last 5 years, Wave Life Sciences' Total Liabilities grew by 23.88% in 2023 and then crashed by 40.73% in 2024.
  • Over the past 5 years, Wave Life Sciences' Total Liabilities (Yearly) stood at $188.6 million in 2020, then fell by 11.64% to $166.6 million in 2021, then increased by 10.18% to $183.6 million in 2022, then grew by 23.88% to $227.4 million in 2023, then slumped by 40.73% to $134.8 million in 2024.